Clinical Trials Directory

Trials / Conditions / Asthma; Eosinophilic

Asthma; Eosinophilic

28 registered clinical trials studyying Asthma; Eosinophilic — 7 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingREverse LuNg Airway and Vascular RemOdeling in Asthma ReMission (ReNORM)
NCT07174713
Western University, CanadaN/A
Not Yet RecruitingHomeostatic Roles of Eosinophils in Asthma
NCT06676397
Centre Hospitalier Universitaire de BesanconN/A
RecruitingSIM0718 Treatment of Asthma Clinical Study
NCT06488755
Simcere Pharmaceutical Co., LtdPhase 3
Not Yet RecruitingNasal Inflammation Following Endotoxin Challenge in Patients With Asthma
NCT06270576
National Jewish HealthPhase 1
RecruitingBenRalizumab Effect on Airway Remodeling in Severe asTHma
NCT06288516
Aristotle University Of ThessalonikiPhase 4
UnknownDupilumab Efficacy on Bronchial Inflammation, Small Airways Disfunction and Mucous Secretion
NCT05787678
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau—
Active Not RecruitingA Real-world, Head-to-head Comparison of Dupilumab Versus Mepolizumab in Danish Patients With Chronic Rhinosin
NCT05942222
Rigshospitalet, DenmarkPhase 4
TerminatedA Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHA
NCT05813288
Areteia TherapeuticsPhase 3
RecruitingMepolizumab and Physical Activity in Severe Asthma
NCT05404763
University Hospital, Lille—
Active Not RecruitingA Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma
NCT05748600
Areteia TherapeuticsPhase 3
TerminatedA Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.
NCT05763121
Areteia TherapeuticsPhase 3
CompletedCharacteristics of Type 2- High Inflammatory Endotype of Asthma Using New Biomarkers From Peripheral Blood and
NCT05270278
Value Outcomes Ltd.—
Active Not RecruitingThe Influence of Mepolizumab on Structural and Inflammatory Cells in Severe Eosinophilic Asthma
NCT05144087
University Hospital Southampton NHS Foundation Trust—
Active Not RecruitingEvaluating the Effect of Benralizumab in Severe, Poorly-controlled Eosinophilic Asthma Using Inhaled Hyperpola
NCT03733535
Dr. Grace ParragaN/A
UnknownThe Influence of Inhaled CorticoSteroids Adherence on Treatment Response to Mepolizumab in Severe Eosinophilic
NCT05241769
University Hospital Birmingham—
CompletedEfficacy of Mepolizumab in Polish Patients With Severe Eosinophilic Asthma
NCT05091385
Medical University of Lodz—
RecruitingPredictive Signature of Benralizumab Response
NCT04565483
Nantes University HospitalPhase 4
CompletedInteraction Between Benralizumab and Basophils in Eosinophilic Asthma
NCT04742504
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz—
UnknownEvaluation of Volatile Organic Compounds in Mepolizumab Therapy
NCT04924478
University Hospital Southampton NHS Foundation Trust—
CompletedEfficacy of Reslizumab Dose Escalation in Patients With Severe Asthma
NCT04710134
McMaster UniversityPhase 4
UnknownEfficacy of Mepolizumab in Severe Asthmatics on a Long Term (MESILICO)
NCT04612556
Aristotle University Of Thessaloniki—
UnknownPatients With Severe Eosinophilic Asthma Treated With Benralizumab
NCT05078281
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla—
CompletedAsthma Control in a Dutch Primary Care Population
NCT04456270
General Practitioners Research Institute—
UnknownFunctional Lung MRI for Early Treatment Response Assessment for Patients With Eosinophilic Asthma
NCT04512521
Hannover Medical School—
UnknownAnti-viral Effects of Azithromycin in Patients With Asthma and COPD
NCT04319705
Bispebjerg HospitalPhase 4
CompletedEffects of Anti-IL5 Biological Treatments on Blood IgE Levels in Severe Asthmatic Patients
NCT04181190
Università degli Studi di Ferrara—
TerminatedEfficacy and Safety of CHF 6532 in Patients With Uncontrolled Severe Eosinophilic Asthma
NCT04049175
Chiesi Farmaceutici S.p.A.Phase 3
CompletedEffect of Mepolizumab on Decrease of Systemic Corticosteroids in Patients With Severe Eosinophilic Asthma
NCT03453021
University Hospital, Grenoble—